2 December 2021

FDA and Patent Strategies for Life Sciences Innovators

Life sciences innovators at all stages seek patent protection to limit market competition and, in some cases, attract further investment. Careful IP planning is especially important in the life sciences, with many companies relying on a handful of patents to protect their high-value products. It is essential that companies pay close attention to the interrelationship between patent and US Food and Drug Administration (FDA) regulatory considerations to protect their most valuable assets for the long term.

This program will provide an overview of the interplay between patent and FDA strategy for pharmaceutical patents, including:

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk